6 completed, 2 terminated, 1 withdrawn. 9 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 9 | Completed 6, Terminated 2, Withdrawn 1 |
| Phase 2 | 1 | Completed 1 |
Follow COVID 19: new trials by email Literature Review of COVID 19 trials Research Report on COVID 19
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function ALG-097558 - COVID 19 | Phase 1 | Completed | Aligos Therapeutics | 12 | 2025-02-20 | 2026-08-25 |
| Colostrum From MERS-CoV Seropositive Camels for SARS-CoV-2 Infection - a Placebo-controlled Randomized Trial. Colostrum Nasal Spray, Water for injection - COVID 19 | Phase 1 / Phase 2 | Completed | Hadassah Medical Organization | 43 | 2023-05-01 | 2025-03-04 |
| Evaluate the Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of HLX71 (Recombinant Human Angiotensin-converting Enzyme 2-Fc Fusion Protein for COVID-19) in Healthy Adult Subjects HLX71, Placebo - COVID 19 | Phase 1 | Completed | Hengenix Biotech Inc | 32 | 2021-04-08 | 2022-04-01 |
| Evaluate Safety and Pharmacokinetics of HLX70 in Healthy Adult Volunteers HLX70, Placebo - COVID 19 | Phase 1 | Withdrawn | Hengenix Biotech Inc | 2020-12-09 | 2022-04-01 | |
| Convalescent Plasma for COVID-19 Patients (CPCP) Convalescent Plasma as Therapy for Covid-19 patients - COVID 19 | Phase 1 | Completed | Vinmec Research Institute of Stem Cell and Gene Technology | 4 | 2020-12-01 | 2024-06-05 |
| Stellate Ganglion Blockade in Corona Virus 2019 (COVID-19) Positive Patients Stellate Ganglion Block - COVID 19, ARDS | Phase 1 | Terminated | University of Nebraska | 1 | 2020-11-15 | 2025-01-20 |
| Anti-SARS Cov-2 T Cell Infusions for COVID 19 Dose Finding Phase (MTD), Partially HLA-matched SARS-CoVSTs, Routine care (no SARS-CoVSTs) - SARS-CoV 2, Viral Infection | Phase 1 | Terminated | Baylor College of Medicine | 4 | 2020-11-04 | 2022-12-19 |
| Vitamin D Testing and Treatment for COVID 19 Vitamin D3 - Covid 19, Vitamin D Deficiency | Phase 1 | Completed | Arizona State University | 41 | 2020-05-19 | 2021-12-30 |
| Effectiveness of Ivermectin as add-on Therapy in COVID-19 Management Ivermectin (IVM) - COVID 19 | Phase 1 | Completed | University of Baghdad | 16 | 2020-04-18 | 2020-11-04 |
COVID-19 (9) · Virus Diseases (1) · Vitamin D Deficiency (1)
Coronaviridae Infections (9) · Coronavirus Infections (9) · Infections (9) · Lung Diseases (9) · Nidovirales Infections (9) · Pneumonia (9) · Pneumonia, Viral (9) · RNA Virus Infections (9) · Respiratory Tract Diseases (9) · Respiratory Tract Infections (9) · Virus Diseases (8) · Avitaminosis (1) · Deficiency Diseases (1) · Malnutrition (1) · Nutrition Disorders (1)
Calcium Dobesilate (1) · Cholecalciferol (1) · Clonidine (1) · Injections (1) · Ivermectin (1) · Maximum Tolerated Dose (1) · Therapeutics (1) · Water (1)
Hengenix Biotech Inc (2) · Aligos Therapeutics (1) · Arizona State University (1) · Baylor College of Medicine (1) · Hadassah Medical Organization (1) · University of Baghdad (1) · University of Nebraska (1) · Vinmec Research Institute of Stem Cell and Gene Technology (1)
United States (5) · Iraq (1) · Israel (1) · Vietnam (1)
Esther Yoon, MD (1) · Faiq I Gorial, Professor (1) · Frank Lee, MD (1) · James B Adams, PhD (1) · Jawad I. Rasheed (1) · Liem Thanh Nguyen, PhD (1) · Michael Lankhorst, MD (1) · Premal Lulla (1) · Sarah Trahan, NMD (1)